Available Until 10/3/2022

What’s on Your List? USP Chapter <800> Risk Assessment and Containment Strategies for Handling Dangerous Drugs

Planned in cooperation with the ASHP Section of Inpatient Care Practitioners

ACPE Activity Number: 0204-0000-19-099-H07-P / 0204-0000-19-099-H07-T
Release Date: October 3, 2019
Expiration Date: October 3, 2022
Activity Type: Knowledge-based  
CE Credits: 1.0 hour, no partial credit
Activity Fee: Members – Free / Non-Member – Not Available  

Accreditation for Pharmacists and Pharmacy Technicians

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Target Audience

This activity was planned to meet the educational needs of pharmacists and pharmacy technicians for assessing risks of exposure to hazardous drugs and strategies to operationalize alternative containment practices.

Activity Overview

The United States Pharmacopeia (USP) has released the final version of Chapter <800> Hazardous Drugs: Handling in Healthcare Settings, and all facilities must be in compliance by December 1, 2019.  One major component of implementation that has left hospitals and health care systems across the nation searching for best practice strategies is the requirement for a hazardous drug list and the performance of an assessment of risk. 

The use of an assessment of risk can help support employee and patient safety, while decreasing the impact to operational workflow, however can only be implemented on selected hazardous medications. The use of an assessment of risk and design of a strategy to ensure success of front line staff can be a challenging, but essential task to the implementation of USP Chapter <800>.  This presentation includes the description of implementation strategies and assessment of risk tools that can be modified for use at health care facilities.

Learning Objectives

  • Discuss a hazardous drug list from required and recommended sources.
  • Identify which medications qualify for an assessment of risk to determine alternative containment strategies.
  • Describe a plan for education and implementation of a hazardous drug list using required USP Chapter <800> controls and assessment of risk alternative containment strategies.

Schedule of Educational Activities

  • Introduction and Announcements
  • Presentation
  • Questions, Answers, and Discussion

Faculty Information

  • Gregory P. Burger, PharmD, CPPS, FASHP, NREMT, Medication Safety Coordinator, Risk Management Department, Stormont Vail Health, Topeka, KS
  • Michael Ganio, Pharm.D., M.S., BCPS, FASHP, Director, Pharmacy Practice and Quality, Center for Medication Safety and Quality, ASHP, Bethesda, MD
  • Bridget Gegorski, Pharm.D., M.S., Medication Safety Officer, University Hospitals, Cleveland, OH

Faculty Disclosures

In accordance with the ACPE's and ACCME's Standards for Commercial Support, anyone in a position to control the content of an educational activity is required to disclose to the accredited provider their relevant financial relationships. In accordance with these Standards, all potential conflicts of interest have been resolved. An individual has a relevant financial relationship if he or she (or spouse/domestic partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.

As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The Standards for Commercial Support do not consider providers of clinical service directly to patients to be commercial interests. The existence or non-existence of relevant financial relationships will be disclosed to the activity audience. All identified conflicts of interest must be resolved prior to the activity.

  • All planners, presenters, reviewers, and ASHP staff report no financial relationships relevant to this activity.

Methods and CE Requirements

This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.

System Technical Requirements

Courses and learning activities are delivered via your Web browser and Acrobat PDF.  Users should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.